DELTAREX-G TUMOR AGNOSTIC THERAPY SHOWS CLINICAL BENEFIT IN CHEMORESISTANT STAGE 4 SARCOMA, PANCREATIC AND BREAST CANCER
AP News,
AUTHORS REPORT ENHANCED CCNG1 EXPRESSION IN 137 SARCOMA, PANCREAS AND BREAST CANCER TUMORS (https://doi.org/10.1158/1538-7445.AM2…